Net loss for the three months ended March 31, 2026, was $1.53 million, compared to $1.74 million in the same period last year. Operating expenses for the quarter were $1.73 million, down from $2.14 million in the prior year quarter. Cash and cash equivalents stood at $13.07 million as of March 31, 2026, down from $34.63 million at June 30, 2025. The company generated $1,250 in revenue for the nine months ended March 31, 2026, from consulting services. Research and development costs for the nine months ended March 31, 2026, were $3.11 million.